Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Regulatory T Cells”

302 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 302 results

Early research (Phase 1)Active Not RecruitingNCT06566261
What this trial is testing

ABA-101 in Participants With Progressive Multiple Sclerosis

Who this might be right for
Progressive Multiple Sclerosis
Abata Therapeutics 12
Not applicableStudy completedNCT02908360
What this trial is testing

Study of the Frequency and of the Regulatory Function of Positive T Lymphocytes Dual CD4CD8aa (DP8a) Specific to a Bacteria of the Intestinal Microbiota (Faecalibacterium Prausnitzii) in Atopic Dermatitis, Asthma and Allergic Rhinitis

Who this might be right for
Allergic AsthmaAllergic RhinitisAtopic Dermatitis
Nantes University Hospital 56
Not applicableStudy completedNCT01233583
What this trial is testing

Regulatory T-cells in Psoriasis Patients as Targets for Therapy

Who this might be right for
Psoriasis
University of Aberdeen 38
Early research (Phase 1)Study completedNCT00626483
What this trial is testing

Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia

Who this might be right for
Malignant Neoplasms Brain
Gary Archer Ph.D. 34
Testing effectiveness (Phase 2)Looking for participantsNCT07473154
What this trial is testing

Controlling Hyperactive Immunity With Long-lived Lymphocytes

Who this might be right for
Diffuse Cutaneous Systemic SclerosisRheumatoid Arthritis (RA)Systemic Sclerosis (SSc)+1 more
Quell Therapeutics Limited 16
Not applicableUnknownNCT00692809
What this trial is testing

Impact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-infection

Who this might be right for
Latent Tuberculosis InfectionHIV InfectionsTuberculosis
Ministry of Science and Technology, India 180
Testing effectiveness (Phase 2)Study completedNCT02474199
What this trial is testing

Donor Alloantigen Reactive Tregs (darTregs) for Calcineurin Inhibitor (CNI) Reduction

Who this might be right for
Liver Transplant RecipientLiving Donor (of the Respective Liver Transplant Recipient)
National Institute of Allergy and Infectious Diseases (NIAID) 15
Early research (Phase 1)Study completedNCT04691232
What this trial is testing

Autologous Ex Vivo Expanded Regulatory T Cells in Ulcerative Colitis

Who this might be right for
Ulcerative ColitisAutoimmune Diseases
University of Erlangen-Nürnberg Medical School 11
Not applicableWithdrawnNCT00370123
What this trial is testing

The Immune Base of Endometriosis

Who this might be right for
Endometriosis
Sheba Medical Center 50
Testing effectiveness (Phase 2)UnknownNCT02519816
What this trial is testing

Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid-refractory or Dependent Chronic GVHD

Who this might be right for
Chronic GVHD After HCT for Cancer or Immune Disease
daphne brockington 17
Testing effectiveness (Phase 2)Study completedNCT04066114
What this trial is testing

Treg Modulation With CD28 and IL-6 Receptor Antagonists

Who this might be right for
Living-Donor Kidney TransplantKidney Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableStudy completedNCT01672151
What this trial is testing

Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenic Purpura
First Affiliated Hospital of Suzhou Medical College 35
Testing effectiveness (Phase 2)Ended earlyNCT01903473
What this trial is testing

Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)

Who this might be right for
Chronic Graft-Versus-Host DiseaseAcute Graft-Versus-Host DiseaseSteroid Refractory Graft-Versus-Host Disease
University of Liege 19
Early research (Phase 1)Study completedNCT04504669
What this trial is testing

First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours

Who this might be right for
Clear Cell Renal Cell CancerNon-Small-Cell Lung CancerTriple Negative Breast Neoplasms+6 more
AstraZeneca 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03867617
What this trial is testing

Cell Therapy for Immunomodulation in Kidney Transplantation

Who this might be right for
Kidney Transplantation
Thomas Wekerle 12
Testing effectiveness (Phase 2)Looking for participantsNCT05468073
What this trial is testing

Therapeutic Evaluation of Low-dose IL-2-based Immunomodulatory Approach in Patients With Early AD

Who this might be right for
Alzheimer Disease
Centre Hospitalier St Anne 45
Not applicableEnded earlyNCT02601690
What this trial is testing

Observational Analysis of T Cell Responses to SPIREs for Multiple Allergens in Subjects With Allergy in North America

Who this might be right for
Allergy
Adiga Life Sciences, Inc. 199
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06180499
What this trial is testing

Allogeneic Immunotherapy of Hematological Malignancies Using Regulatory T-cell Selective Depletion

Who this might be right for
Hematological MalignanciesRegulatory T Cell DepletionRelapse
Assistance Publique - Hôpitaux de Paris 27
Not applicableUnknownNCT06119451
What this trial is testing

The Role of Traditional Music Therapy on Burnout Syndrome Among Healthcare Workers: Psycho-Neuro-Immuno-Endocrine Aspects

Who this might be right for
Burnout, Professional
Indonesia University 80
Large-scale testing (Phase 3)UnknownNCT03236129
What this trial is testing

Allogeneic Immunotherapy for Hematological Malignancies by Selective Depletion of Regulatory T Cells

Who this might be right for
Hematological MalignanciesRegulatory T Cell DepletionRelapse
Assistance Publique - Hôpitaux de Paris 52
Load More Results